Welcome
Support Centre
09 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Effects of different intensities of exercise on health risk factors
ISRCTN ISRCTN43414825
ClinicalTrials.gov identifier NCT00955071
Public title Effects of different intensities of exercise on health risk factors
Scientific title Dose-response effects of exercise on abdominal obesity and risk factors for cardiovascular disease (CVD) in women and men
Acronym SERENA
Serial number at source MCT-190617
Study hypothesis The driving hypothesis is that the attenuation of health risk with exercise is largely explained by associated reductions in abdominal obesity, in particular visceral fat. Specifically, we will test the following hypotheses:
1. That by comparison to controls, all treatments will be associated with reduction in abdominal subcutaneous, visceral fat, liver fat and insulin resistance
2. That reduction in abdominal subcutaneous, visceral and liver fat and insulin resistance in high volume low intensity exercise (HVLI) and low volume high intensity exercise (LVHI) will be greater than low volume low intensity exercise (LVLI)
3. That hypotheses 1 and 2 are true independent of gender
Ethics approval Queen’s University, Faculty of Health Sciences Research Ethics Board (REB) approved on the 22nd July 2009 (ref: PHE-093-09)
Study design Randomised controlled trial
Countries of recruitment Canada
Disease/condition/study domain Cardiometabolic risk
Participants - inclusion criteria 1. Men and women between 40 and 60 years of age. The lower age range for men and women is selected to help ensure recruitment of a sample with metabolic syndrome as prevalence of metabolic syndrome is significantly related to age. The selection of 60 years for the upper age range reflects concerns we have randomising older adults to the high intensity exercise group wherein exercise at 75 - 80% of maximum may be difficult to achieve, and likely to be associated with increased orthopaedic injury and thus, poor compliance. We also considered lowering the lower age range from 40 to 35 years, but decided against doing so to increase the cost-effectiveness of recruitment (e.g., ensure a higher yield of those with metabolic syndrome)
2. Abdominally obese (waist circumference greater than 88 and 102 cm for women and men respectively) and National Cholesterol Education Program, Adult Treatment Panel III (NCEP-ATPIII) defined metabolic syndrome. Abdominal obesity for non-Caucasians will be determined using values suggested by the International Diabetes Federation.
3. Sedentary lifestyle (planned physical activity for the purpose of health one day per week or less)
4. Weight stable (± 2 kg) for 6 months prior to the beginning of the study
5. Body mass index (BMI) less than 40 kg/m^2 (because a lifestyle-based intervention alone for obesity reduction is ideal for persons with a BMI less than 40 kg/m^2)
Participants - exclusion criteria 1. Physical impairment which would make the intervention very difficult, or unsafe according to the patient's physician including history of myocardial infarction, stroke, coronary bypass surgery or angioplasty in the last 6 months; peripheral artery disease, unstable angina or ischaemia
2. Diabetes
3. Current smokers
4. Alcohol consumption greater than 21 drinks per week
5. Plans to move from the area
6. Participating in another research study
7. Clinically judged to be unsuitable for participation or adherence as determined by the participants physician
8. Inability or unwillingness to provide informed consent
9. For women, planned pregnancy in the next year
Anticipated start date 01/09/2009
Anticipated end date 31/08/2013
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 320
Interventions The intervention (duration of treatment) will be six months and the negative energy balance will be induced by the increase in exercise alone (e.g., no caloric restriction).

1. No exercise, wait list control group
2. Low volume (180 kcal), low intensity (50%) exercise group
3. High volume (360 kcal), low intensity (50%) exercise group
4. Low volume (180 kcal), high intensity (75%) exercise group
Primary outcome measure(s) Waist circumference and 2-hour glucose, measured at baseline, 16, 24 and 48 weeks
Secondary outcome measure(s) Measured at baseline, 16, 24 and 48 weeks:
1. Visceral fat
2. Metabolic syndrome variables (glucose, systolic and diastolic blood pressure, triglycerides and high density lipoprotein [HDL]-cholesterol)
Sources of funding Canadian Institutes of Health Research (CIHR) (Canada) - http://www.cihr-irsc.gc.ca (ref: MCT-190617)
Trial website
Publications
Contact name Prof  Robert  Ross
  Address Queen's University
School of Kinesiology and Health Studies
28 Division Street
  City/town Kingston
  Zip/Postcode K7L 3N6
  Country Canada
  Email rossr@queensu.ca
Sponsor Queen's University (Canada)
  Address Office of Research Services
Fleming Hall/Jemmett Wing, 3rd floor
78 Fifth Field Company Lane
  City/town Kingston, Ontario
  Zip/Postcode K7L 3N6
  Country Canada
  Tel +1 613 533 6081
  Fax +1 613 533 6806
  Email woods@queensu.ca
  Sponsor website: http://www.queensu.ca/ors/contact.html
Date applied 09/02/2010
Last edited 11/02/2010
Date ISRCTN assigned 11/02/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central